Rishabh Pharmaceuticals Private Limited

Rishabh Pharmaceuticals Private Limited

This company manufactures and trades pharmaceutical products, chemicals, and other related items.
2010 | Indore, Madhya Pradesh (India) | Active

Last Updated:

November 17, 2024
HomeCompanyRishabh Pharmaceuticals Private Limited

Who are the key members and board of directors at Rishabh Pharmaceuticals?

Board Members(2)

NameDesignationAppointment DateStatus
Arpit Sanghavi In Director 03-May-2010Current
Anil Kumar In Director 03-May-2010Current

Financial Performance of Rishabh Pharmaceuticals.

Rishabh Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.21% decrease. The company also saw a substantial fall in profitability, with a 94.15% decrease in profit. The company's net worth moved up by a moderate rise of 1.21%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-23.21%
Revenue from Operations
-23.20%
Total Assets
-7.80%
Profit or Loss
-94.15%
Net Worth
1.21%
EBITDA
-50.06%

Charges (Loans)

Open Charges Satisfied Charges

₹4.95 M

₹20.00 M

LenderAmountStatus

State Bank Of India

Creation Date: 20 Oct 2022
₹2.70 MOpen

State Bank Of India

Creation Date: 20 Oct 2022
₹2.25 MOpen

State Bank Of India

Creation Date: 13 Feb 2015
₹2.00 CrSatisfied

How Many Employees Work at Rishabh Pharmaceuticals?

Unlock and access historical data on people associated with Rishabh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Rishabh Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Rishabh Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Rishabh Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.

    31 Mar 2024

  • Charges

    A charge with State Bank Of India amounted to Rs. 2.70 M with Charge ID 100624129 was registered on 20 Oct 2022.

    20 Oct 2022

  • Charges

    A charge with State Bank Of India amounted to Rs. 2.25 M with Charge ID 100624131 was registered on 20 Oct 2022.

    20 Oct 2022

  • Charges

    A charge registered on 13 Feb 2015 via Charge ID 10555969 with State Bank Of India was fully satisfied on 09 Jul 2021.

    09 Jul 2021

  • Charges

    A charge with State Bank Of India amounted to Rs. 20.00 M with Charge ID 10555969 was registered on 13 Feb 2015.

    13 Feb 2015

Frequently asked questions

  • Rishabh Pharmaceuticals Private Limited was incorporated on 03 May 2010.

  • The authorized share capital of Rishabh Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.34 M.

  • Currently 2 directors are associated with Rishabh Pharmaceuticals Private Limited.

    • Anil Sanghvi Kumar
    • Arpit Sanghavi
  • As per Ministry of Corporate Affairs (Mca), the registered address of Rishabh Pharmaceuticals Private Limited is 47/3 Vallabh Nagar India, Indore, Madhya Pradesh, 452003.

  • The corporate identification number (CIN) of Rishabh Pharmaceuticals Private Limited is U24232MP2010PTC023483 and the company number is 023483 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Rishabh Pharmaceuticals Private Limited has fallen by -23.21%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Rishabh Pharmaceuticals Private Limited has experienced an upsurge of 1.21%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Rishabh Pharmaceuticals Private Limited amount to ₹ 4.95 M.

  • The most recent Balance Sheet for Rishabh Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development